Results

Total Results: over 10,000 records

Showing results for "harms".

  1. srdr.ahrq.gov/projects/1671/studies/196143
    January 01, 2015 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
  2. srdr.ahrq.gov/projects/1671/studies/196142
    What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
  3. srdr.ahrq.gov/projects/1671/studies/196147
    January 01, 1997 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
  4. srdr.ahrq.gov/projects/1671/studies/196172
    January 01, 1999 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
  5. srdr.ahrq.gov/projects/1671/studies/196185
    January 01, 1991 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
  6. srdr.ahrq.gov/projects/1671/studies/196154
    January 01, 2010 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
  7. srdr.ahrq.gov/projects/1671/studies/196145
    January 01, 2011 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
  8. srdr.ahrq.gov/projects/1671/studies/196162
    January 01, 1996 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
  9. srdr.ahrq.gov/projects/1671/studies/196175
    January 01, 2015 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
  10. srdr.ahrq.gov/projects/1671/studies/196184
    January 01, 1991 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
  11. srdr.ahrq.gov/projects/1671/studies/196178
    What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
  12. srdr.ahrq.gov/projects/1671/studies/196150
    What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
  13. srdr.ahrq.gov/projects/1671/studies/196157
    January 01, 1992 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
  14. srdr.ahrq.gov/projects/1671/studies/196173
    What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
  15. srdr.ahrq.gov/projects/1671/studies/196186
    What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
  16. www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/lipid-disorders-children-adolescents-screening
    May 13, 2021 - What are the harms of screening for FH or multifactorial dyslipidemia in children and adolescents? … What are the harms of treatment of FH or multifactorial dyslipidemia in children and adolescents? … ): Psychosocial effects Overdiagnosis False positives/negatives    KQ 5 (Treatment Harms) … : All harms from: Lipid-lowering medications (e.g., adverse events, long-term safety, overtreatment … Study design KQ 1 (Screening benefits): RCTs, CCTs KQs 2, 3, 5 (Yield, screening and treatment harms
  17. www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/syphilis-infection-pregnant-persons
    December 01, 2022 - What are the harms of screening for syphilis in pregnant persons? … What are the harms of treatment of syphilis with penicillin during pregnancy to pregnant persons or newborns … Comparisons KQ 1: No screening KQ 2: No comparator necessary for studies on psychosocial harms … of screening (e.g., false-positive and false-negative results, stigma, psychosocial harms) KQ 3: … , Jarish-Herxheimer reaction, fetal harms, other maternal harms) Cost-effectiveness or cost-related
  18. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/47434/psn-pdf
    January 21, 2019 - Estimating the hospital costs of inpatient harms. January 21, 2019 Anand P, Kranker K, Chen AY. … Estimating the hospital costs of inpatient harms. … https://psnet.ahrq.gov/issue/estimating-hospital-costs-inpatient-harms Pressure ulcers, surgical site … infections, and other hospital-acquired conditions are common preventable harms in hospitals. … https://psnet.ahrq.gov/issue/estimating-hospital-costs-inpatient-harms https://psnet.ahrq.gov/primer/
  19. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/44056/psn-pdf
    May 19, 2018 - Impact of inpatient harms on hospital finances and patient clinical outcomes. … Impact of Inpatient Harms on Hospital Finances and Patient Clinical Outcomes. … https://psnet.ahrq.gov/issue/impact-inpatient-harms-hospital-finances-and-patient-clinical-outcomes … the Institute for Healthcare Improvement's global trigger tool to examine how all-cause inpatient harmsharms result in negative financial outcomes for hospitals.
  20. www.uspreventiveservicestaskforce.org/home/getfilebytoken/TEqfQsqZ92eykPeTQBZx-h
    March 12, 2012 - outweigh the harms. … The harms of screening earlier than age 21 years outweigh the benefits. … The benefits of screening after age 65 years do not outweigh the potential harms. … The harms of screening after hysterectomy outweigh the benefits. … The potential harms of screening with HPV testing (alone or with cytology) outweigh the potential